Clinical trial
A Cohort Study of Serological Responses to MVA-BN Smallpox Vaccine (Imvamex®) Administered During a Monkeypox Outbreak in the UK
NCT03745131 is registered in ClinicalTrials.gov with Public Health England as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Cohort Study of Serological Responses to MVA-BN Smallpox Vaccine (Imvamex®) Administered During a Monkeypox Outbreak in the UK
- Lead sponsor
- Public Health England
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 30, 2018
- Completion date
- November 30, 2019
- Enrollment
- 120 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
monkeypox